Drug
Bexicaserin clinical trials
Also written LP352.
Keep track of what changes. Save the bexicaserin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
5 studies that test it; most in 2022 (2)
| Year | Studies |
|---|---|
| 2022 | 2 |
| 2024 | 2 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 0
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses bexicaserin is read from its arms, and is right about nine times in ten.
Testing it · 5
- A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)Enrolling by invitationPhase 3Longboard PharmaceuticalsNCT06908226Written as LP352
- A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)Active, not recruitingPhase 3Longboard PharmaceuticalsNCT06660394Written as LP352
- A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE)Active, not recruitingPhase 3Longboard PharmaceuticalsNCT06719141Written as LP352
- Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic EncephalopathyCompletedPhase 2Longboard PharmaceuticalsNCT05626634Written as LP352, bexicaserin
- Study to Investigate LP352 in Subjects With Developmental and Epileptic EncephalopathiesCompletedPhase 1/2Longboard PharmaceuticalsNCT05364021Written as LP352
Codes
What other systems call bexicaserin · ClinicalTrials.gg INT017775
- UNII (FDA) R8XR1D6SCBBEXICASERINOne source FDA
- NCI Thesaurus C203219BexicaserinOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | R8XR1D6SCB | BEXICASERIN | One source FDA |
| NCI Thesaurus | C203219 | Bexicaserin | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.